DSM to Supply Cancer Drug for Eisai
Eisai says its US supply agreement with DSM offers an alternate manufacturing facility and ensures a strengthened supply line.
Archives for March 5, 2013
update
SAFC Expands Manufacturing Capacity to Meet Growing EU Needs
SAFC will expand manufacturing capacity at its facility in Irvine, Scotland, to include large-scale production of bulk dry powder media and reagents to save EU clients’ money in shipment costs.
Sanofi to Provide API for Allergy Therapies
Sanofi has entered into an agreement to produce an API for French company DBV Technologies.